Comparison

Toceranib

Item no. V3698-500mg
Manufacturer InvivoChem LLC
CASRN 356068-94-5
Amount 500 mg
Quantity options 100 mg 1 g 250 mg 2 g 50 mg 5 g
Category
Type Biochemicals
Specific against other
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Description
InvivoChem Cat #:V3698CAS #:356068-94-5 Purity >=98%

Description: Toceranib (formerly known as PHA-291639, or SU 11654) is an inhibitor of receptor tyrosine kinase (RTK) with Ki values of 6 nM and 5 nM for Flk-1/KDR and PDGFRbeta, respectively. It is used in the treatment of canine mast cell tumor (also called mastocytoma). Toceranib is an veterinary drug that was approved for use in dog. Toceranib is likely to act mostly through inhibition of the kit tyrosine kinase, though it may also have an anti-angiogenic effect.

References: 2012 Mar-Apr; 26(2):355-62; 2014 May 6; 10:105.

Related CAS#:874819-74-6 (phosphate)

Molecular Weight (MW)
396.47
Formula
C22H25FN4O2
CAS No.
356068-94-5 (free base);
Storage
-20C for 3 years in powder form
-80C for 2 years in solvent
Solubility (In vitro)
DMSO: 10 mM
Water: < 1mg/mL
Ethanol: < 1mg/mL
Chemical Name
(Z)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2, 4-dimethyl-N-(2-(pyrrolidin-1-yl)ethyl)-1H-pyrrole-3-carboxamide
Synonyms
SU-11654; SU 11654; SU11654; PHA-291639; PHA291639; PHA 291639; Toceranib; Trade name: Palladia.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close